STX-241 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: PFL-241

Filter by location:

Nashville, Tennessee1 trial

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

Sarah Cannon Research Institute (SCRI) (The SCRI Oncology Research Consortium)

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.